You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

enzalutamide

Showing 51 - 75 of 183
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Boston (Tivozanib, Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 25, 2021

Metastatic Hormone-Sensitive Prostate Cancer Trial in China (biological, drug, procedure, other)

Active, not recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer
  • Pembrolizumab
  • +3 more
  • Beijing, Beijing, China
  • +23 more
Sep 30, 2022

Prostate Cancer Trial in Ann Arbor, Detroit (ARRx, Enzalutamide)

Suspended
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +1 more
Dec 17, 2021

Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer Trial in United States (NUV-868, Olaparib, Enzalutamide)

Recruiting
  • Advanced Solid Tumor
  • +26 more
  • Baltimore, Maryland
  • +3 more
Aug 1, 2022

Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)

Completed
  • Advanced Epithelial Ovarian
  • +3 more
  • Enzalutamide
  • Basking Ridge, New Jersey
  • +5 more
Mar 4, 2022

Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)

Recruiting
  • Prostate Cancer
  • Metastatic Prostate Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Feb 21, 2023

Prostatic Tumors, Pelvic Nodal Trial in San Francisco (Enzalutamide, Leuprolide, Intensity-Modulated Radiation Therapy)

Terminated
Has Results
  • Prostatic Neoplasms
  • Pelvic Nodal
  • Enzalutamide
  • +2 more
  • San Francisco, California
    University of California San Francisco
Sep 14, 2021

Metastatic Castration-Resistant Prostate Cancer Trial in Australia (Lu-PSMA, Enzalutamide)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • Camperdown, New South Wales, Australia
  • +12 more
Feb 14, 2022

Progressive Metastatic Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)

Active, not recruiting
Has Results
  • Progressive Metastatic Prostate Cancer
  • Enzalutamide
  • Placebo
  • Beijing, China
  • +46 more
Jan 13, 2023

Breast Cancer, Early Stage, Triple Negative Breast Cancer Trial in United States (Enzalutamide, assessment)

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Enzalutamide
  • assessment
  • Hartford, Connecticut
  • +11 more
Apr 26, 2022

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer Trial in New Brunswick (drug, other, procedure)

Terminated
  • Clear Cell Renal Cell Carcinoma
  • Stage I Renal Cell Cancer
  • Enzalutamide
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 14, 2021

Castration-resistant Prostate Cancer Trial in Osaka (Enzalutamide, Flutamide)

Completed
  • Castration-resistant Prostate Cancer
  • Osaka, Japan
    Osaka City University Graduate School of Medicine
Sep 8, 2021

Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, enzalutamide, abiraterone acetate)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Chengdu, China
  • +7 more
Aug 5, 2022

Adenocarcinoma of the Prostate Trial in United States (Enzalutamide, SRT)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • Enzalutamide
  • SRT
  • Washington, District of Columbia
  • +8 more
Feb 3, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,

Active, not recruiting
Has Results
  • Estrogen Receptor Negative
  • +6 more
  • Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +8 more
Feb 3, 2022

Intermediate Risk Prostate Cancer Trial in Boston (Enzalutamide, External Beam Radiation)

Active, not recruiting
  • Intermediate Risk Prostate Cancer
  • Enzalutamide
  • External Beam Radiation
  • Boston, Massachusetts
  • +2 more
Jul 26, 2021

Metastatic Castration-Resistant Prostate Cancer Trial in United States (ZEN003694, Enzalutamide)

Completed
Has Results
  • Metastatic Castration-Resistant Prostate Cancer
  • Los Angeles, California
  • +7 more
Nov 2, 2021

Pancreatic Cancer Trial in Tampa (Enzalutamide, Gemcitabine, Nab-paclitaxel)

Completed
  • Pancreatic Cancer
  • Enzalutamide
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 16, 2021

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Axillary Lymph Node Dissection
  • +5 more
  • Houston, Texas
  • +1 more
Mar 10, 2022

Prostate Cancer Trial in Shatin (Apalutamide, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Shatin, Hong Kong
    Prince of Wales Hospital
Aug 3, 2021

Metastatic Prostate Cancer in Pirkanmaa Hospital District in

Not yet recruiting
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 17, 2023

Metastatic Hormone Sensitive Prostate Cancer Treated With

Not yet recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • Innsbruck, Austria
  • +42 more
Jun 5, 2023

Ann Arbor Stage I Mantle Cell Lymphoma, Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma Trial

Terminated
Has Results
  • Ann Arbor Stage I Mantle Cell Lymphoma
  • +5 more
  • Enzalutamide
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 16, 2021

Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Enzalutamide, Docetaxel, Prednisolone)

Active, not recruiting
Has Results
  • Metastatic Castration Resistant Prostate Cancer
  • Enzalutamide
  • +3 more
  • Linz, Austria
  • +88 more
Dec 22, 2022

Prostate Adenocarcinoma Trial in Washington (Entinostat, Enzalutamide)

Terminated
  • Prostate Adenocarcinoma
  • Washington, District of Columbia
    George Washington University - Medical Faculty Associates
Jul 26, 2021